Question 1

What is Oncternal Therapeutics Inc (ONCT) stock price today?

Accepted Answer

Oncternal Therapeutics Inc (ONCT) currently trades at $0.53 per share. The stock has a market capitalization of $1.56M and a P/E ratio of —x.

Question 2

Is ONCT stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Oncternal Therapeutics Inc has a Smart Value Score of 43/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Oncternal Therapeutics Inc's revenue and earnings?

Accepted Answer

Oncternal Therapeutics Inc has trailing twelve-month (TTM) revenue of $2.16M with profit margins of 0.00%. Earnings per share (EPS) is $-11.69.

Question 4

Is ONCT stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Oncternal Therapeutics Inc's intrinsic value is $3.03, representing a margin of safety of 82.62%. The stock currently trades at a P/E of —x.

Metric	2020	2021	2022	2023	TTM
Revenue	$3.38M	$4.32M	$1.49M	$785000.00	$2.16M
Net income	$-17.21M	$-31.30M	$-43.39M	$-39.48M	$-8.46M
EPS	—	—	—	—	$-11.69
Free cash flow	$-17.50M	$-26.59M	$-36.70M	$-32.16M	$-6.95M
Profit margin	-509.90%	-725.38%	-2,912.28%	-5,029.17%	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ONCT	$1.56M	43	5.3	2.5	6.7	5.0	+82.62%	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Oncternal Therapeutics Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare